Literature DB >> 20332238

PTPH1 dephosphorylates and cooperates with p38gamma MAPK to increase ras oncogenesis through PDZ-mediated interaction.

Song-Wang Hou1, Hui-Ying Zhi, Nicole Pohl, Mathew Loesch, Xiao-Mei Qi, Rong-Shan Li, Zainab Basir, Guan Chen.   

Abstract

Protein phosphatases are believed to coordinate with kinases to execute biological functions, but examples of such integrated activities, however, are still missing. In this report, we have identified protein tyrosine phosphatase H1 (PTPH1) as a specific phosphatase for p38gamma mitogen-activated protein kinase (MAPK) and shown their cooperative oncogenic activity through direct binding. p38gamma, a Ras effector known to act independent of its phosphorylation, was first shown to require its unique PDZ-binding motif to increase Ras transformation. Yeast two-hybrid screening and in vitro and in vivo analyses further identified PTPH1 as a specific p38gamma phosphatase through PDZ-mediated binding. Additional experiments showed that PTPH1 itself plays a role in Ras-dependent malignant growth in vitro and/or in mice by a mechanism depending on its p38gamma-binding activity. Moreover, Ras increases both p38gamma and PTPH1 protein expression and there is a coupling of increased p38gamma and PTPH1 protein expression in primary colon cancer tissues. These results reveal a coordinative oncogenic activity of a MAPK with its specific phosphatase and suggest that PDZ-mediated p38gamma/PTPH1 complex may be a novel target for Ras-dependent malignancies.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20332238      PMCID: PMC2848905          DOI: 10.1158/0008-5472.CAN-09-3229

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  31 in total

1.  PTPH1 is a predominant protein-tyrosine phosphatase capable of interacting with and dephosphorylating the T cell receptor zeta subunit.

Authors:  Margaret S Sozio; Meredith A Mathis; Jennifer A Young; Sebastien Wälchli; Lisa A Pitcher; Philip C Wrage; Beatrix Bartók; Amanda Campbell; Julian D Watts; Ruedi Aebersold; Rob Hooft van Huijsduijnen; Nicolai S C van Oers
Journal:  J Biol Chem       Date:  2003-12-12       Impact factor: 5.157

2.  Crosstalk between cAMP-dependent kinase and MAP kinase through a protein tyrosine phosphatase.

Authors:  M Saxena; S Williams; K Taskén; T Mustelin
Journal:  Nat Cell Biol       Date:  1999-09       Impact factor: 28.824

3.  Somatic mutations in PTPN11 in juvenile myelomonocytic leukemia, myelodysplastic syndromes and acute myeloid leukemia.

Authors:  Marco Tartaglia; Charlotte M Niemeyer; Alessandra Fragale; Xiaoling Song; Jochen Buechner; Andreas Jung; Karel Hählen; Henrik Hasle; Jonathan D Licht; Bruce D Gelb
Journal:  Nat Genet       Date:  2003-06       Impact factor: 38.330

4.  PTEN activation contributes to tumor inhibition by trastuzumab, and loss of PTEN predicts trastuzumab resistance in patients.

Authors:  Yoichi Nagata; Keng-Hsueh Lan; Xiaoyan Zhou; Ming Tan; Francisco J Esteva; Aysegul A Sahin; Kristine S Klos; Ping Li; Brett P Monia; Nina T Nguyen; Gabriel N Hortobagyi; Mien-Chie Hung; Dihua Yu
Journal:  Cancer Cell       Date:  2004-08       Impact factor: 31.743

5.  Mechanism of p38 MAP kinase activation in vivo.

Authors:  Deborah Brancho; Nobuyuki Tanaka; Anja Jaeschke; Juan-Jose Ventura; Nyaya Kelkar; Yoshinori Tanaka; Masanao Kyuuma; Toshikazu Takeshita; Richard A Flavell; Roger J Davis
Journal:  Genes Dev       Date:  2003-07-31       Impact factor: 11.361

6.  Stress- and mitogen-induced phosphorylation of the synapse-associated protein SAP90/PSD-95 by activation of SAPK3/p38gamma and ERK1/ERK2.

Authors:  Guadalupe Sabio; Suzana Reuver; Carmen Feijoo; Masato Hasegawa; Gareth M Thomas; Francisco Centeno; Sven Kuhlendahl; Sergio Leal-Ortiz; Michel Goedert; Craig Garner; Ana Cuenda
Journal:  Biochem J       Date:  2004-05-15       Impact factor: 3.857

7.  Mutational analysis of the tyrosine phosphatome in colorectal cancers.

Authors:  Zhenghe Wang; Dong Shen; D Williams Parsons; Alberto Bardelli; Jason Sager; Steve Szabo; Janine Ptak; Natalie Silliman; Brock A Peters; Michiel S van der Heijden; Giovanni Parmigiani; Hai Yan; Tian-Li Wang; Greg Riggins; Steven M Powell; James K V Willson; Sanford Markowitz; Kenneth W Kinzler; Bert Vogelstein; Victor E Velculescu
Journal:  Science       Date:  2004-05-21       Impact factor: 47.728

8.  SmgGDS is up-regulated in prostate carcinoma and promotes tumour phenotypes in prostate cancer cells.

Authors:  H Zhi; X J Yang; J Kuhnmuench; T Berg; R Thill; H Yang; W A See; C G Becker; C L Williams; R Li
Journal:  J Pathol       Date:  2009-02       Impact factor: 7.996

9.  p38 MAPK activation selectively induces cell death in K-ras-mutated human colon cancer cells through regulation of vitamin D receptor.

Authors:  Xiaomei Qi; Jun Tang; Rocky Pramanik; Richard M Schultz; Senji Shirasawa; Takehiko Sasazuki; Jiahuai Han; Guan Chen
Journal:  J Biol Chem       Date:  2004-03-22       Impact factor: 5.157

Review 10.  Targeting RAS signalling pathways in cancer therapy.

Authors:  Julian Downward
Journal:  Nat Rev Cancer       Date:  2003-01       Impact factor: 60.716

View more
  38 in total

1.  MAPKs' status at early stages of renal carcinogenesis and tumors induced by ferric nitrilotriacetate.

Authors:  Francisco A Aguilar-Alonso; José D Solano; Chabetty Y Vargas-Olvera; Ignacio Pacheco-Bernal; Telma O Pariente-Pérez; María Elena Ibarra-Rubio
Journal:  Mol Cell Biochem       Date:  2015-02-28       Impact factor: 3.396

2.  Is p38γ MAPK a metastasis-promoting gene or an oncogenic property-maintaining gene?

Authors:  Fanyan Meng; Guojun Wu
Journal:  Cell Cycle       Date:  2013-07-15       Impact factor: 4.534

3.  The K-Ras effector p38γ MAPK confers intrinsic resistance to tyrosine kinase inhibitors by stimulating EGFR transcription and EGFR dephosphorylation.

Authors:  Ning Yin; Adrienne Lepp; Yongsheng Ji; Matthew Mortensen; Songwang Hou; Xiao-Mei Qi; Charles R Myers; Guan Chen
Journal:  J Biol Chem       Date:  2017-07-24       Impact factor: 5.157

4.  Protein tyrosine phosphatase PTPN3 inhibits lung cancer cell proliferation and migration by promoting EGFR endocytic degradation.

Authors:  M-Y Li; P-L Lai; Y-T Chou; A-P Chi; Y-Z Mi; K-H Khoo; G-D Chang; C-W Wu; T-C Meng; G-C Chen
Journal:  Oncogene       Date:  2014-09-29       Impact factor: 9.867

Review 5.  Cell Signaling and Stress Responses.

Authors:  Gökhan S Hotamisligil; Roger J Davis
Journal:  Cold Spring Harb Perspect Biol       Date:  2016-10-03       Impact factor: 10.005

6.  Molecular Basis of the Interaction of the Human Protein Tyrosine Phosphatase Non-receptor Type 4 (PTPN4) with the Mitogen-activated Protein Kinase p38γ.

Authors:  Pierre Maisonneuve; Célia Caillet-Saguy; Marie-Christine Vaney; Edoo Bibi-Zainab; Kristi Sawyer; Bertrand Raynal; Ahmed Haouz; Muriel Delepierre; Monique Lafon; Florence Cordier; Nicolas Wolff
Journal:  J Biol Chem       Date:  2016-05-31       Impact factor: 5.157

7.  p38γ Mitogen-activated protein kinase signals through phosphorylating its phosphatase PTPH1 in regulating ras protein oncogenesis and stress response.

Authors:  Songwang Hou; Padmanaban S Suresh; Xiaomei Qi; Adrienne Lepp; Shama P Mirza; Guan Chen
Journal:  J Biol Chem       Date:  2012-06-22       Impact factor: 5.157

8.  p38γ mitogen-activated protein kinase (MAPK) confers breast cancer hormone sensitivity by switching estrogen receptor (ER) signaling from classical to nonclassical pathway via stimulating ER phosphorylation and c-Jun transcription.

Authors:  Xiaomei Qi; Huiying Zhi; Adrienne Lepp; Phillip Wang; Jian Huang; Zainab Basir; Christopher R Chitambar; Charles R Myers; Guan Chen
Journal:  J Biol Chem       Date:  2012-03-07       Impact factor: 5.157

Review 9.  Genetic profiling of intrahepatic cholangiocarcinoma and its clinical implication in targeted therapy.

Authors:  Diyang Xie; Zhenggang Ren; Jia Fan; Qiang Gao
Journal:  Am J Cancer Res       Date:  2016-02-15       Impact factor: 6.166

10.  p38gamma MAPK cooperates with c-Jun in trans-activating matrix metalloproteinase 9.

Authors:  Mathew Loesch; Hui-Ying Zhi; Song-Wang Hou; Xiao-Mei Qi; Rong-Shan Li; Zainab Basir; Thomas Iftner; Ana Cuenda; Guan Chen
Journal:  J Biol Chem       Date:  2010-03-15       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.